SCHEMBL25334955

SCHEMBL25334955

Nc1ncnc2c1ncn2N1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O

nearest known ligand 0.63

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ P2RX3 P56373 5/20 0.63
▸ P2RX1 P51575 4/20 0.63
▸ P2RX2 Q9UBL9 3/20 0.63
▸ P2RY1 P47900 6/20 0.60
▸ P2RY2 P41231 3/20 0.60
▸ P2RX4 Q99571 3/20 0.60
▸ ALDH1A1 P00352 2/20 0.60
▸ SRC P12931 1/20 0.60
▸ SMN1; SMN2 Q16637 1/20 0.60
▸ RNASEL Q05823 1/20 0.59
▸ TRPM2 O94759 2/20 0.57
▸ MACROD2 A1Z1Q3 1/20 0.57
▸ SIRT6 Q8N6T7 1/20 0.57
▸ MACROD1 Q9BQ69 1/20 0.57
▸ ENPP1 P22413 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29436002 0.79 ADORA3 (0.55) ALDH1A1SMN1; SMN2
Adenosine Triphosphate SCHEMBL4362224 0.79 P2RY1 (0.94) P2RX3P2RX1P2RX2P2RY1P2RY2
Adenosine Triphosphate SCHEMBL468214 0.79 P2RY1 (0.94) P2RX3P2RX1P2RX2P2RY1P2RY2
SCHEMBL9171542 0.79 P2RY1 (0.94) P2RX3P2RX1P2RX2P2RY1P2RY2
SCHEMBL4366441 0.79 P2RY1 (0.94) P2RX3P2RX1P2RX2P2RY1P2RY2
Adenosine Triphosphate SCHEMBL8980 0.79 P2RY1 (0.94) P2RX3P2RX1P2RX2P2RY1P2RY2
SCHEMBL4997435 0.79 P2RY1 (0.94) P2RX3P2RX1P2RX2P2RY1P2RY2
Adenosine Triphosphate SCHEMBL18089781 0.79 P2RY1 (0.94) P2RX3P2RX1P2RX2P2RY1P2RY2
Adenosine Triphosphate SCHEMBL20550531 0.79 P2RY1 (0.94) P2RX3P2RX1P2RX2P2RY1P2RY2
SCHEMBL376009 0.79 P2RY1 (0.94) P2RX3P2RX1P2RX2P2RY1P2RY2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023144193-A1 MRNAS FOR TREATMENT OF HEREDITARY TYROSINEMIA TYPE I CureVac SE (DE) 2023-08-03 — — WO disclosed
Send feedback